An organic reductant, in particular an organo silicon reductant suitable for activating supported catalysts of the type MO.sub.nE.sub.m, wherein E is S and/or Se, in particular MO.sub.n, wherein M is W, Mo or Re, is described as well as its use in metathesis reactions. The reduced catalysts are able to metathesize olefins at low temperatures and are therefore also suitable for metathesis of functionalized olefins.

An organic reductant, in particular an organo silicon reductant suitable for activating supported catalysts of the type MO.sub.nE.sub.m, wherein E is S and/or Se, in particular MO.sub.n, wherein M is W, Mo or Re, is described as well as its use in metathesis reactions. The reduced catalysts are able to metathesize olefins at low temperatures and are therefore also suitable for metathesis of functionalized olefins.

The present invention provides a method for the preparation of a sex pheromone of Obsucure Mealy bug (OMB), (plus/minus) (2,3,4,4-tetramethycyclopentyl)methyl acetate. The method comprises a step of subjecting alpha-halotetramethylcyclohexanone to a Favorskii rearrangement to obtain a 2,3,4,4-tetramethylcyclopentane compound (2), a step of subjecting said compound (2) to reduction to obtain (2,3,4,4-tetramethylcyclopentyl)methanol (3) and a step of subjection said compound (3) to acylation to obtain a (2,3,4,4-tetramethylcyclopentyl)methyl carboxylate compound (4).

The present invention provides a method for the preparation of a sex pheromone of Obsucure Mealy bug (OMB), (plus/minus) (2,3,4,4-tetramethycyclopentyl)methyl acetate. The method comprises a step of subjecting alpha-halotetramethylcyclohexanone to a Favorskii rearrangement to obtain a 2,3,4,4-tetramethylcyclopentane compound (2), a step of subjecting said compound (2) to reduction to obtain (2,3,4,4-tetramethylcyclopentyl)methanol (3) and a step of subjection said compound (3) to acylation to obtain a (2,3,4,4-tetramethylcyclopentyl)methyl carboxylate compound (4).

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.

The present invention relates to monoterpenoid and phenylpropanoid containing derivative compounds, methods of making the compounds, compositions comprising the compounds, and methods of repelling pests using the compounds and/or compositions.

The present invention relates to monoterpenoid and phenylpropanoid containing derivative compounds, methods of making the compounds, compositions comprising the compounds, and methods of repelling pests using the compounds and/or compositions.

The invention provides methods of synthesizing compounds in an asymmetric or enantioenriched fashion, wherein the compounds are useful intermediates in the synthesis of viral protease inhibitors.

The invention provides methods of synthesizing compounds in an asymmetric or enantioenriched fashion, wherein the compounds are useful intermediates in the synthesis of viral protease inhibitors.